Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-14

Clinical Trial Update: The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing infliximab to methotrexate in adults with moderate-to-severe psoriasis has completed and posted results. The trial evaluated the effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)
  • Trexall (Methotrexate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2009-07-14